Sage Journals: Discover world-class research

Abstract

Weight-based, nurse-driven heparin nomograms are reported in the medical literature to improve the time it takes to reach a minimum threshold for anticoagulation without compromising patient safety in specific indications or patient populations. This is the first report in the literature of an institution-wide protocol implementation and evaluation of effectiveness with simultaneous transition to an electronic health record. The purpose of implementing this practice change at our institution was to standardize practice, improve time to reach therapeutic anticoagulation, and improve patient safety. We conducted a retrospective analysis utilizing a pre/postimplementation design to compare outcomes. The primary end point evaluated was the time to reach minimum threshold value for therapeutic anticoagulation. Additionally, we assessed the percentage of patients who reached minimum threshold therapeutic anticoagulation within 24 hours, the percentage of patients with a critically supratherapeutic activated partial thromboplastin time (aPTT) value (≥120 seconds) during therapy, and a description of heparin titration for the first 4 aPTT results with nomogram use. Overall time to therapeutic anticoagulation decreased from a mean 18.7 to 11.7 hours (hazard ratio [HR] 1.59; 95% confidence interval 1.22-2.08; P < .0005). Percentage of patients receiving therapeutic anticoagulation within 24 hours increased from 74.4 to 88.5 (odds ratio [OR 2.97, P = .002) and the percentage of patients with an aPTT ≥120 seconds remained constant at 49.9 versus 46.8 (OR 0.92, P = .73). This practice change reduced time to therapeutic anticoagulation without an increase in the proportion of patients with a critically supratherapeutic aPTT at our institution.

Keywords

heparin nomogram anticoagulation titration

Get full access to this article

View all access options for this article.

References

Raschke

Reilly

Guidry

Fontana

Srinivas

. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial. Ann Intern Med. 1993;119(9):874–881.

Brown

Dodek

. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit. Crit Care Med. 1997;25(9):1534–1538.

Shalansky

FitzGerald

Sunderji

. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Pharmacotherapy. 1996;16(6):1076–1084.

Abraham

. Technological trends in health care: electronic health record. Health Care Manag (Frederick). 2010;29(4):318–323.

Hirsh

Dalen

Deykin

Poller

. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1992;102(suppl 4):337S–351S.

Hirsh

Warkentin

Shaughnessy

. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(suppl 1):64S–94S.

Bates

Weitz

. Coagulation assays. Circulation. 2005;112(4):e53–e60.

Takemoto

Streiff

Shermock

. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance. Am J Clin Pathol. 2013;139(4):450–456.

Basu

Gallus

Hirsh

Cade

. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med. 1972;287(7):324–327.

10.

Hull

Raskob

Brant

Pineo

Valentine

. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 1997;157(22):2562–2568.

11.

Granger

Hirsch

Califf

. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation. 1996;93(5):870–878.

12.

Morabia

. Heparin doses and major bleedings. Lancet. 1986;1(8492):1278–1279.

13.

Reilly

Raschke

Srinivas

Nieman

. Intravenous heparin dosing: patterns and variations in internists’ practices. J Gen Intern Med. 1993;8(10):536–542.

14.

Cruickshank

Levine

Hirsh

Roberts

Siguenza

. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med. 1991;151(2):333–337.

15.

Jaff

Olin

Piedmonte

Pirzada

Young

. Heparin administration via nomogram versus a standard approach in venous and arterial thromboembolic disease. Vasc Med. 1996;1(2):97–101.

16.

Williams

Sullivan

Lacey

Adoryan

Watts

. Nurse-driven intravenous heparin protocol: quality improvement initiative. AACN Adv Crit Care. 2010;21(2):152–161.

17.

Rivey

Peterson

. Pharmacy-managed, weight-based heparin protocol. Am J Hosp Pharm. 1993;50(2):279–284.

18.

Oyen

Nishimura

Armon

Zhou

. Effectiveness of a computerized system for intravenous heparin administration: using information technology to improve patient care and patient safety. Am Heart Hosp J. 2005;3(2):75–81.

19.

Saya

Coleman

Martinoff

. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm. 1985;42(9):1965–1969.

20.

Hohlfelder

Stashek

Anger

Szumita

. Utilization of a pharmacy clinical surveillance system for pharmacist alerting and communication at a tertiary academic medical center. J Med Syst. 2016;40(1):24.

21.

Wilson

Sullivan

. Preventing medication errors with smart infusion technology. Am J Health Syst Pharm. 2004;61(2):177–183.

22.

Rothschild

Keohane

Cook

. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33(3):533–540.

23.

Hull

Raskob

Rosenbloom

. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 1992;152(8):1589–1595.

24.

Hull

Raskob

Hirsh

. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986;315(18):1109–1114.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB

0.05 MB

Description and Evaluation of the Implementation of a Weight-Based,Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center

Abstract

Keywords

Get full access to this article

References

Supplementary Material